Combination of peroxisome proliferator-activated receptor α/γ agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion

Patients with type 2 diabetes mellitus (T2DM) have a higher risk of cardiovascular disease (CVD). Peroxisome proliferator-activated receptors (PPARs) play an important role in the regulation of energy homeostasis. Therefore, we aimed to observe the effects of combined PPARα/γ agonists on T2DM patien...

Descripción completa

Detalles Bibliográficos
Autores principales: WEI, JINRU, TANG, QUAN, LIU, LIJUAN, BIN, JIANBIN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570181/
https://www.ncbi.nlm.nih.gov/pubmed/23408783
http://dx.doi.org/10.3892/etm.2013.891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570181/
https://www.ncbi.nlm.nih.gov/pubmed/23408783
http://dx.doi.org/10.3892/etm.2013.891

Ejemplares similares